Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CV Sciences (CVSI) Equity Average (2016 - 2025)

CV Sciences (CVSI) has disclosed Equity Average for 14 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Equity Average fell 24.56% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, down 24.56% year-over-year, with the annual reading at $1.6 million for FY2025, 30.54% down from the prior year.
  • Equity Average hit $1.5 million in Q4 2025 for CV Sciences, down from $1.7 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $11.6 million in Q1 2021 to a low of $294000.0 in Q4 2022.
  • Historically, Equity Average has averaged $3.9 million across 5 years, with a median of $2.5 million in 2024.
  • Biggest five-year swings in Equity Average: crashed 96.0% in 2022 and later soared 985.37% in 2023.
  • Year by year, Equity Average stood at $7.3 million in 2021, then plummeted by 96.0% to $294000.0 in 2022, then skyrocketed by 985.37% to $3.2 million in 2023, then plummeted by 37.54% to $2.0 million in 2024, then decreased by 24.56% to $1.5 million in 2025.
  • Business Quant data shows Equity Average for CVSI at $1.5 million in Q4 2025, $1.7 million in Q3 2025, and $1.8 million in Q2 2025.